Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
Baoling Ying, Bradley Whitener, Laura A. VanBlargan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22

Showing 22 citing articles:

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Alexandra C. Walls, Kaitlin R. Sprouse, John E. Bowen, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 872-880.e3
Open Access | Times Cited: 197
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice
Suzanne M. Scheaffer, Diana Lee, Bradley Whitener, et al.
Nature Medicine (2022) Vol. 29, Iss. 1, pp. 247-257
Open Access | Times Cited: 150
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters
Michael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 85
COVID-19 Delta Variant: Perceptions, Worries, and Vaccine-Booster Acceptability among Healthcare Workers
Khalid Alhasan, Fadi Aljamaan, Mohamad‐Hani Temsah, et al.
Healthcare (2021) Vol. 9, Iss. 11, pp. 1566-1566
Open Access | Times Cited: 69
Mapping SARS-CoV-2 antigenic relationships and serological responses
Samuel Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 61
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Jun Liu, Patrick Budylowski, Reuben Samson, et al.
Science Advances (2022) Vol. 8, Iss. 3
Open Access | Times Cited: 41
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice
Baoling Ying, Suzanne M. Scheaffer, Bradley Whitener, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 38
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 27
SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect against evolving variants.
Melanie L. Carroll, Heather Fox, Anh Tran, et al.
Vaccine (2025) Vol. 54, pp. 126988-126988
Open Access
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant
Suzanne M. Scheaffer, Diana Lee, Bradley Whitener, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 26
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
Soledad Henriquez, Jérémie Zerbit, Timothée Bruel, et al.
Blood (2021) Vol. 139, Iss. 6, pp. 942-946
Open Access | Times Cited: 29
Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern
Bassel Akache, Tyler M. Renner, Matthew Stuible, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 20
Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters
James Brett Case, Suzanne M. Scheaffer, Tamarand L. Darling, et al.
Journal of Virology (2023) Vol. 97, Iss. 9
Open Access | Times Cited: 11
Interpretable and Predictive Deep Modeling of the SARS-CoV-2 Spike Protein Sequence
Bahrad A. Sokhansanj, Zhengqiao Zhao, Gail Rosen
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Approaches to evaluate the specific immune responses to SARS-CoV-2
Ana López-Gomez, Hector F. Pelaez-Prestel, Ignacio Juárez
Vaccine (2023) Vol. 41, Iss. 43, pp. 6434-6443
Open Access | Times Cited: 4
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
Alexandra C. Walls, Kaitlin R. Sprouse, Anshu Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
Samantha Mackin, Pritesh Desai, Bradley Whitener, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
S. Momsen Reincke, Meng Yuan, Hans‐Christian Kornau, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
An Immunostimulatory Glycolipid That Blocks SARS-CoV-2, RSV, and Influenza Infections In Vivo
David D. Ho, Moriya Tsuji, Manoj S. Nair, et al.
Research Square (Research Square) (2023)
Open Access
A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses
Katarzyna Kuczkowska, Louise Bjerkan, Elisabeth Stubsrud, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access
Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine
Yangtao Wu, Shaojuan Wang, Yali Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
An Immunostimulatory Glycolipid That Blocks SARS-CoV-2, RSV, and Influenza Infections In Vivo
David D. Ho, Moriya Tsuji, Manoj S. Nair, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top